Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FK914
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,546
Award facts
- Contract value 100% obligated
- $56,545.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $56,545.89 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains and has demonstrated capability to meet federal procurement requirements through open competition. This delivery order for Enbrel, a brand-name medication used in rheumatoid arthritis and other autoimmune conditions, exemplifies the company's role in supplying specialty medications to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FK914?
SPE2DR26FK914 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FK914 worth?
The government has obligated $56,546 on SPE2DR26FK914.
Is contract SPE2DR26FK914 an order under another contract?
Yes. SPE2DR26FK914 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK914 competed?
The extent of competition for SPE2DR26FK914 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award